Finding the right treatment for each patient is the very foundation of healthcare. If we push this principle to the extreme, precision medicine is one of the best ways to fight cancer. However, the economists Samuel Kembou and Bruno Ventelou found that, for advanced non-small cell lung cancer, there is inequality in access to this type of personalized treatment in France.
